IP Library Granted Patent US 7,872,096
Granted Patent B2
US 7,872,096 · App. 11/136,806 · Granted Jan 18, 2011

Methods for cyclizing synthetic polymers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,872,096
App. No.
11/136,806
Granted
Jan 18, 2011
Kind
B2
Abstract

The invention provides methods and compositions for production of a cyclic polymer in a cell free system. In general, the methods of the invention involve ligating first and second recombinant intein domains to a linear synthetic polymer to form a compound containing the structure: D 1 -X (n) -D 2 , where D 1 is a first catalytic domain of an intein; D 2 is a second catalytic domain of an intein; where the second catalytic domain has at its N-terminus a first reactive site for the intein; and X (n) is a polymer of a number n of monomer X, where the polymer N-terminus has a second reactive site for the intein. D 1 -X (n) -D 2 compounds autocatalytically cyclize the X (n) polymer to produce a cyclic polymer. The invention finds use in a variety of drug discovery, clinical and therapeutic applications.

Claims (31)

1. A method comprising:

native chemical ligating a first isolated intein domain D 1 and a second isolated intein domain D 2 to-polymer X (n) in a cell-free system to produce a compound comprising the structure:

D 1 -X (n) -D 2

wherein:

polymer X (n) comprises n residues of a monomer X, wherein n is at least 2, and polymer X (n) is not made up of only naturally-occurring amino acid monomers;

said compound comprises a first intein reactive site at the N-terminus of polymer X (n) ;

said compound comprises a second intein reactive site at the N-terminus of D 2 ; and

said compound produces a cyclic product comprising said polymer, wherein said cyclic product is cyclized via a reaction that joins said first intein reactive site and said second intein reactive site.

2. The method of claim 1 , wherein said ligating comprises:

ligating said first intein domain D 1 with said polymer X (n) to produce a compound of the formula:

D 1 -X (n)

wherein D 1 and X (n) are joined by a first peptide bond; and,

ligating said second isolated intein domain D 2 with said polymer X (n) to produce a compound of the formula:

D 1 -X (n) -D 2

wherein D 1 and X (n) are joined by a second peptide bond.

3. The method of claim 1 , wherein said ligating comprises:

ligating a first intein domain D 1 having a C-terminal reactive thioester with said polymer X (n) , said polymer X (n) having an N-terminal sulfhydryl group and a protected C-terminal thioester group, said ligating producing a compound of the formula:

D 1 -X (n) —Z

wherein polymer X (n) comprises n residues of a monomer X, wherein n is at least 2, and Z is said protected C-terminal thioester group,

deprotecting said protected C-terminal thioester group to produce a C-terminal reactive thioester group; and

ligating said C-terminal reactive thioester group with said second intein domain D 2 having an N-terminal sulfhydryl group to produce a compound of the formula:

D 1 -X (n) -D 2

4. The method of claim 1 , wherein said polymer comprises at least one non-naturally occurring monomer.

5. The method of claim 1 , wherein said polymer comprises at least one amino acid monomer.

6. The method of claim 1 , wherein said polymer comprises at least one nucleotide monomer.

7. The method of claim 1 , wherein said first and second intein reactive sites comprise sulfhydryl or hydroxyl moieties.

8. The method of claim 7 , wherein said first and second intein reactive sites comprise cysteine, alanine or serine, or an analog thereof.

9. The method of claim 1 , wherein said polymer is a homopolymer.

10. The method of claim 1 , wherein said polymer is a heteropolymer.

11. The method of claim 1 , further comprising incubating said compound under intein reaction conditions to produce said cyclic product.

12. The method of claim 1 , wherein said polymer is synthetically made.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2005
From: KINSELLA, TODD M.
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 016584/0567 →